# EDGAR Filing Document

**Accession Number:** 0001923840
**File Stem:** 0001193125-25-139141
**Filing Date:** 2025-6
**Character Count:** 6555
**Document Hash:** c6799c12c742de7d157dd548bf0b2eeb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-139141.hdr.sgml**: 20250611

**ACCESSION NUMBER**: 0001193125-25-139141

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250605

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20250611

**DATE AS OF CHANGE**: 20250611

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Third Harmonic Bio, Inc.
- **CENTRAL INDEX KEY:** 0001923840
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 834553503
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41498
- **FILM NUMBER:** 251039958

**BUSINESS ADDRESS:**
- **STREET 1:** 1700 MONTGOMERY STREET
- **STREET 2:** SUITE 210
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94111
- **BUSINESS PHONE:** 2097272457

**MAIL ADDRESS:**
- **STREET 1:** 1700 MONTGOMERY STREET
- **STREET 2:** SUITE 210
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94111

?xml version='1.0' encoding='ASCII'? 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### WASHINGTON, D.C. 20549

### FORM 8-K

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d)

#### of the Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): June 5, 2025

## THIRD HARMONIC BIO, INC.

#### (Exact name of Registrant as Specified in Its Charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41498** | **83-4553503** |
| **(State or Other Jurisdiction**<br> **of Incorporation)** | **(Commission**<br> **File Number)** | **(IRS Employer**<br> **Identification No.)** |

---

---

| | |
|:---|:---|
| **1700 Montgomery Street, Suite 210** |  |
| **San Francisco, California** | **94111** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

#### Registrant's Telephone Number, Including Area Code: 209 727-2457

#### N/A

#### (Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

#### Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br> **Symbol(s)** | **Name of each exchange**<br> **on which registered** |
| Common Stock, par value $0.0001 per share | THRD | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 5.07.** | **Submission of Matters to a Vote of Security Holders.**  |

---

On June 5, 2025, Third Harmonic Bio, Inc. (the "**Company**") held its 2025 Annual Meeting of Stockholders and the following proposals were adopted:

1. Election of three Class III directors, identified in the table below, each to serve a three-year term which will expire at the 2028 Annual Meeting of Stockholders and until such time as their respective successors have been duly elected and qualified or until their earlier resignation or removal. The vote tally was as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Nominees** | **Shares**<br>**For** | **Shares**<br>**For** | **Shares**<br>**Withheld** | **Shares**<br>**Withheld** | **Broker**<br>**Non-Votes** | **Broker**<br>**Non-Votes** |
|  Thomas M. Soloway |  | 35527334 |  | 2237476 |  | 5607546 |
|  David Bonita, M.D. |  | 34965535 |  | 2799275 |  | 5607546 |
|  Goeff McDonough, M.D. |  | 35902845 |  | 1861965 |  | 5607546 |

---

2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. The vote tally was as follows:

---

| | | |
|:---|:---|:---|
| **Shares**<br> **For** | **Shares**<br> **Against** | **Shares**<br> **Abstaining** |
| 43370492 | 1082 | 782 |

---

3. Approval of the liquidation and dissolution of the Company, which, if approved, will authorize the Board of Directors of the Company (the "**Board**") to liquidate and dissolve the Company in accordance with the Plan of Dissolution described in the Company's Definitive Proxy Statement on [Schedule 14A](http://www.sec.gov/Archives/edgar/data/1923840/000095017023014106/thrd-def_14a-2023.htm) , filed with the SEC on April 25, 2025 (the "**Dissolution Proposal** "). The vote tally was as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Shares**<br> **For** | **Shares**<br> **Against** | **Shares**<br> **Abstaining** | **Broker**<br> **Non-Vote** |
| 37762990 | 216 | 1604 | 5607546 |

---

------

4. Approval to grant discretionary authority to the Board to adjourn the 2025 Annual Meeting of Stockholders, even if a quorum is present, to solicit additional proxies in the event that there are insufficient shares present in person or by proxy voting in favor of the Dissolution Proposal. The vote tally was as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Shares**<br> **For** | **Shares**<br> **Against** | **Shares**<br> **Abstaining** | **Broker**<br> **Non-Vote** |
| 37419829 | 343280 | 1701 | 5607546 |

---

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  |  | **THIRD HARMONIC BIO, INC.** |
| Date: June 11, 2025 | By: | */s/ Chris Murphy* |
|  |  | Chris Murphy |
|  |  | Chief Financial and Business Officer |

---